Generation Lab is a San-Francisco–based longevity science company whose flagship product, SystemAge™, quantifies biological age by analyzing primary blood data and evaluating the health of 19 physiological systems. The platform relies on hundreds of millions of human-aging data points and proprietary algorithms that achieve 99.9% diagnostic accuracy, offering clinicians and consumers actionable insights to slow or reverse organ-specific aging. Launched less than ten months ago, the company has already partnered with more than 275 clinics worldwide and amassed over 300 million data points, reflecting rapid commercial traction. Early clinical studies have shown measurable reversals of brain, reproductive, heart and immune system ages after targeted interventions, underscoring its clinical relevance. Generation Lab’s customer base includes academic medical centers, professional athletes, celebrities, and leading longevity physicians. Backed by prominent scientific advisors such as Harvard’s David Sinclair and George Church, the company aims to make proactive longevity diagnostics a global standard of care. With $15 million in total funding, Generation Lab plans to accelerate adoption of SystemAge™ and continue expanding its dataset and intervention roadmap.

Total raised

$11M

Funding rounds

2

Latest round

Seed

Latest activity

Oct 2025